Patent litigation finance booming while insurance market evolving, providers say
Industry practitioners remain optimistic against an unstable financial backdrop
Industry practitioners remain optimistic against an unstable financial backdrop
QTL General Manager John Han speaks to IAM about essentiality checks and valuation during negotiations as well as future pool participation
Companies are failing to conduct proper due diligence assessments that consider intangible assets, which is proving detrimental to their organisation’s true value.
In deal with Xiaomi, Wilus Institute is latest research group out of Seoul to find a market in China for young, high-quality rights
18 August 2020
Dragon Wang of Sitao IP says Huawei v Conversant judgment out of Nanjing is not as damaging for licensors as it may appear
14 August 2020
Oncology licensing, smaller acquisitions and abundant venture capital provide means of commercialising innovation during M&A decline
13 August 2020
Why analysts must look beyond traditional valuation methodologies to an alternative ‘real options’ framework
12 August 2020
The pandemic has puts compulsory licensing firmly on the agenda in the country that is friendliest to life sciences IP owners
11 August 2020
No fewer than 17 companies have had listing plans scuppered due to a variety of IP deficiencies
10 August 2020
Exclusive analysis of the recently published full judgment of the Nanjing Intermediate People's Court in Huawei v Conversant
05 August 2020
Publicly-quoted companies in the IAM/ktMINE US Patent 100 enjoyed a strong June compared to their peers
31 July 2020
Move to implement patent linkage is the clearest sign yet that the country is embracing pharma and biotech innovation
30 July 2020
Deal creates an IP behomoth and continues the trend towards service provider consolidation - but the new company's clients will need reassurances
29 July 2020
Unlock unlimited access to all IAM content